Diclofenac Sodium 25 Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg, 50 mg, 75 mg, 100 mg
Reference Brands: Voltaren(US), Voltarol (EU)
Category:
Arthritis
Diclofenac inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which alleviates pain, inflammation, and fever. Benefits include effective relief of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions, offering rapid pain reduction, improved joint function, and a well-established safety profile when used appropriately.
Diclofenac Sodium 25 mg tablets is available in Tablets
and strengths such as 25 mg, 50 mg, 75 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Diclofenac Sodium 25 mg tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Diclofenac Sodium 25 mg tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
iclofenac tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In the EU, brands like Voltaren and Cataflam are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for diclofenac tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy, helping you meet regulatory requirements seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing